Emergency vaccination programmes have reportedly diminished deaths by about 60% over the past 23 years while also preventing similar infection numbers. The study specifically evaluated incidents related to five infectious diseases, including Ebola, cholera, and yellow fever, across 210 different instances in 49 countries from 2000 to 2023. Not only has the implementation of vaccines shown impressive mortality reduction, but an estimated economic benefit of $32 billion has emerged, predominantly from averting deaths and years lost to disability. This figure likely underestimates the overall savings, excluding costs of wider outbreaks or significant health emergencies.
Emergency vaccination programmes have reduced deaths by around 60% over 23 years, preventing similar infections and stopping larger outbreaks of diseases like Ebola.
The economic benefits of vaccination programmes are estimated to be worth $32 billion, primarily from averting deaths and disability.
This is the first comprehensive study assessing the impact of emergency vaccination programmes for Ebola, measles, cholera, yellow fever, and meningitis across 210 incidents.
The study reveals that the swift deployment of vaccines not only reduces mortality but also prevents the wider outbreak of contagious diseases.
Collection
[
|
...
]